Bionano Genomics Inc
(BNGO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 24,571 | 140,736 | 332,554 | 362,057 | 38,449 |
| Marketable Securities | 226,041 | 185,333 | N/A | N/A | N/A |
| Receivables | 4,934 | 2,996 | 2,838 | 1,992 | 2,775 |
| Inventories | 12,387 | 9,020 | 4,890 | 3,036 | 3,315 |
| TOTAL | $272,414 | $342,047 | $341,965 | $370,251 | $46,789 |
| Non-Current Assets | |||||
| PPE Net | 10,318 | 8,554 | 6,084 | 5,806 | 4,910 |
| Intangibles | 83,002 | 8,411 | 8,490 | 8,569 | 8,648 |
| Other Non-Current Assets | 11,366 | 645 | 270 | 235 | 103 |
| TOTAL | $104,686 | $17,610 | $14,844 | $14,610 | $13,661 |
| Total Assets | $377,100 | $359,657 | $356,809 | $384,861 | $60,450 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 10,769 | 7,875 | 3,745 | 2,209 | 2,930 |
| Accrued Expenses | 8,621 | 9,416 | 6,540 | 4,659 | 5,599 |
| Other current liabilities | 684 | 411 | 445 | 301 | 416 |
| TOTAL | $21,840 | $17,702 | $10,730 | $7,169 | $8,945 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | N/A | 14,866 | 16,325 |
| Other Non-Current Liabilities | 14,500 | 390 | 213 | 108 | 98 |
| TOTAL | $18,142 | $390 | $213 | $14,974 | $16,423 |
| Total Liabilities | $39,982 | $18,092 | $10,943 | $22,143 | $25,368 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 484 | 483 | 466 | 466 | 465 |
| Common Shares | 29 | 28 | 28 | 28 | 19 |
| Retained earnings | -216,119 | -193,170 | -172,417 | -153,631 | -143,684 |
| Other shareholders' equity | -539 | -116 | 0 | 0 | 0 |
| TOTAL | $337,118 | $341,565 | $345,866 | $362,718 | $35,082 |
| Total Liabilities And Equity | $377,100 | $359,657 | $356,809 | $384,861 | $60,450 |